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Aim. CO326 is a chicken nuclear scaffold/matrix attachment region (MAR) associated with the nuclear
matrix in several types of chicken cells. It contains a binding site for a sequence-specific DNA-binding
protein, F326. We have studied its interaction with the nuclear matrix. Methods. We have used an in vitro
MAR assay with isolated matrices from chicken HD3 cells. Results. We have found that an oligonucleotide
binding site for the F326 inhibits binding of the CO326 to the nuclear matrix. At the same time, the binding
of heterologous MARs is enhanced. Conclusions. Taken together, these data suggest that there exist several
classes of MARs and MAR-binding domains and that the MAR-binding proteins may be clustered in the
nuclear matrix.
Keywords: nuclear matrix, DNA-protein interactions, MAR, SAR.
Introduction.  Chromatin of interphase eukaryotic
nuclei and metaphase chromosomes is compacted into
large loops (for review see [1, 2]). The loops are fixed
onto a proteinaceous skeletal structure designated as
the nuclear skeleton, scaffold, or matrix [3]. Positions
of the anchorage sites of the DNA loops on the nuclear
matrix were shown to be non-random, and were
mapped in many species ranging from yeast to man (for 
review see [4, 5]).
A simple method has been developed for mapping
nuclear matrix attachment sites in cloned DNA using
an in vitro binding assay. The method is based on
binding in vitro of labelled DNA fragments to the
isolated nuclear matrix. In the presence of non-specific
competitor DNA, only DNA fragments that possess a
high affinity for the nuclear matrix bind. These
fragments were designated as Matrix Association
Regions or «MARs» [6] or Scaffold Attachment
Regions or «SARs» [7]. In the modern literature MARs 
and SARs are often called S/MARs, according to the
suggestion of Bode [8]. In some cases MARs are
indeed attached to the nuclear matrix in vivo [9].
However many MARs reside in loop DNA and can be
easily extracted from nuclei pre-treated with nucleases
[10].
While in vivo function of MARs is not clear, it has
been shown that they stimulate replication of plasmids
in yeasts [11] and of episomal DNA in cells of higher
eukaryotes [12], are necessary for correct expression of 
immunoglobulin genes [13], and for integration site-
independent expression of genes (for review see [14]).
It is generally believed that most MARs mapped using
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evolutionarily conserved [15]. This statement is
obviously in contradiction with the diversity of
functions attributed to MARs (for review see [5]). We
have decided to explore the extent of diversity in
known SAR/MAR elements using the classical in vitro
MAR assay.
Earlier we have cloned several chicken DNA
fragments attached to the nuclear matrix in the nuclei of 
chicken erythrocytes. One of these MARs designated
as CO326 was shown to interact with a sequence-
specific DNA-binding protein F326 which recognised
a motif TCACTGCAGACCGCTTCG [16, 17].
In the present study, we addressed the question of
functional heterogeneity of MARs by using the in vitro
MAR assay using other known MARs and the
oligonucleotide binding site for the F326 protein. We
have shown that the protein is involved in binding of
the CO326 MAR to the nuclear matrix. At the same
time, binding of heterologous MARs is enhanced in the 
presence of an oligonucleotide harbouring F326
binding site suggesting the structural and functional
heterogeneity of the nuclear matrix binding sites in the
chromatin.
Materials and Methods. Cells and tissues. AEV-
transformed chicken erythroblasts HD3 were cultured
as described [18].
Plasmids and oligonucleotides. The CO326
fragment was excised from the CO326-pTZ construct
[17] by BamHI digestion. Double-stranded oli-
gonucleotides 5'-GATCCTCACTGCAGACCGCTTCG-3'
(F326) and 5'-TATTTGATAGCAATATTTAGTATTT-3'
(control) were ordered from Operon (Germany) as
complementary single-stranded oligonucleotides and
then annealed according to the manufacturer’s
protocol.
The isolation of nuclear matrices and the MAR
assay was carried out essentially as described [6, 19].
In short, nuclear matrices were prepared by incubation
of isolated nuclei from the HD3 cells with DNase I and
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Fig. 1. A – CO326 fragment has an S/MAR activity. End-labelled CO326 fragment and a mixture of control end-labelled DNA fragments,
one of which contained a chicken MAR, were added to the isolated nuclear matrices along with the unlabelled competitor DNA as described
in the «Methods» section, incubated at room temperature for 2 h and washed with the incubation buffer. Matrix-bound DNA was purified by
phenol extraction, electrophoretically separated in a polyacrylamide gel and autoradiographed. 1 –50 % of the input DNA; 2–4 – incubation
of the labelled DNA in the presence of sonicated salmon sperm DNA added as a competitor (0, 0.5, 0.1 and 0.25 mg/ml, respectively); B – the 
F326 oligonucleotide binding site efficiently competes with the CO236 S/MAR. End-labelled CO326 fragment and a control end-labelled
DNA fragment with no affinity to the nuclear matrix were added to the nuclear matrices along with the unlabelled competitor DNA as des-
cribed in the «Methods» section, incubated at room temperature for 2 h and washed with the incubation buffer. Matrix-bound DNA was
purified by phenol extraction, electrophoretically separated in a polyacrylamide gel and autoradiographed. 1 – 50 % of the input DNA; 2 –
incubation of the labelled DNA in the presence of sonicated salmon sperm DNA added as a competitor (0.25 mg/ml); 3 – same as 2, but a 25-
fold molar excess of the oligonucleotide containing binding site for F326 was added as a competitor along with the salmon sperm DNA; 4 –
the same as 2, but a 50-fold molar excess of the oligonucleotide containing binding site for F326 was added as a competitor along with the
salmon sperm DNA. Arrows indicate the positions of the control MAR and the CO326 DNA; 5 – the same as 2, but a 50-fold molar excess of
a heterologous oligonucleotide (5'-TATTTGATAGCAATATTTAGTATTT-3') was added as a competitor along with the salmon sperm DNA;
C – The F326 oligonucleotide binds to the nuclear matrix. End-labelled F326 oligonucleotide and the control end-labelled oligonucleotide
(5'-TATTTGATAGCAATATTTAGTATTT-3') were added to the nuclear matrices along with the unlabelled competitor DNA as described in
the «Methods» section, incubated at room temperature for 2 h and washed with the incubation buffer. Matrix-bound DNA was purified by
phenol extraction, electrophoretically separated in a polyacrylamide gel and autoradiographed. 1 – 50 % of the input DNA; 2–4 – incubation
of the labelled DNA in the presence of sonicated salmon sperm DNA added as a competitor (0, 0.1, 0.25 and 0.05 mg/ml, respectively)a subsequent extraction with 2 M NaCl. Fifty nano-
grams of end-labelled DNA fragments and different
amounts of unlabelled competitor DNA (sonicated sal-
mon sperm DNA) were added to nuclear matrices isola- 
ted from 2×10
7 cells, and incubated at a room tempera-
ture for 2 h in a buffer containing 50 mM NaCl, 10 mM
Tris-HCl, pH 7.4, 2 mM EDTA, 0.25 mM sucrose; then 
the non-bound DNA was removed by repeated washing 
with the incubation buffer. Nuclear matrices were di-
gested by overnight treatment with SDS and proteinase
K. Matrix-bound DNA was purified by phenol extrac-
tion and the initial complete set of labelled DNA frag-
ments was compared to the matrix-bound and non-
bound DNA fractions by electrophoresis in agarose or
polyacrylamide gels followed by auto-radiography. In
some experiments, a double-stranded oligonucleotide
binding site for a nuclear matrix protein F326 [17]
(5'-GATCCTCACTGCAGACCGCTTCG-3') was added
as a competitor. 
Results and Discussion. A nuclear matrix DNA
fragment containing the F326 binding site specifically
binds to the nuclear matrix in an in vitro assay. To
study the role of the F326 protein in attachment of
DNA to the nuclear matrix we have used an in vitro
S/MAR assay. The CO326 S/MAR was end-labelled
and mixed with the equal molar amounts of plasmid
DNA with no affinity for the nuclear matrix as a
negative control and the well-studied chicken S/MAR
from the domain of alpha-globin genes [20]. The
mixture of DNA fragments was incubated with the
nuclear matrix preparations in the presence of
increasing concentrations of competitor DNA, as
described in the «Methods» section. After incubation,
the matrices were washed with several volumes of the
incubation buffer to remove the non-bound probe, and
the matrix-bound DNA was recovered by proteinase
digestion of the matrix. The pattern of input and
matrix-bound labelled DNA were compared by
electrophoresis.
Indeed, both the CO326 S/MAR and the control
S/MAR (was preferentially associated with the nuclear
matrix while the control fragment, had a much less
affinity to the nuclear matrix. Thus, the data obtained
demonstrate that the studied fragment contains an in
vitro S/MAR activity (Fig. 1, A).
Oligonucleotide containing binding site for the
F326 protein binds to the isolated nuclear matrix and
inhibits binding of the CO326 S/MAR to the nuclear
matrix. Next we checked whether the F326 binding site 
is necessary for attachment to the nuclear matrix by
competing the binding of the CO326 S/MAR to the
nuclear matrix with the oligonucleotide containing the
binding site for the F326 protein. The MAR assay
carried out in the presence of the 25 bp-long double-
stranded oligonucleotide demonstrated that its 50-fold
molar excess completely inhibited binding of the
500 bp-long S/MAR to the nuclear matrix (Fig. 1, B). In 
order to find out whether the observed effect was deter-
mined by specific or non-specific competition, we have 
tried to compete the CO326 S/MAR using a double-
stranded oligonucleotide that had no homologies with
the studied S/MAR (5'-TATTTGATAGCAATATTTA-
GTATTT-3'). No significant competition was observed
(Fig. 1, B). The above observations strongly suggest
that the F326 protein most probably mediates DNA
attachment to the nuclear matrix.
A competition between the CO326 S/MAR and the
F326 oligo suggests that latter also interacts with the
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Fig. 2. A – F326 oligonucleotide increases binding of heterologous
S/MARs to the nuclear matrix in vitro. MAR assay of the human
MAR from the beta-interferon gene domain [21]. End-labelled con-
trol DNA, CO326 DNA, and either a S/MAR from the beta-inter-
feron gene domain (A) or a S/MAR from the chicken alpha-globin
gene domain (B) were added to the isolated nuclear matrices along
with the unlabelled competitor DNA as described in the «Methods»
section, incubated at room temperature for 2 h and washed with the
incubation buffer. Matrix-bound DNA was purified by phenol ex-
traction, electrophoretically separated in a polyacrylamide gel and
autoradiographed. 1 – 5 % of the input DNA; 2 – incubation of the
labelled DNA in the presence of sonicated salmon sperm DNA ad-
ded as a competitor (0.25 mg/ml); 3 – same as 2, but a 25-fold molar
excess of the oligonucleotide binding site for F326 was added as a
competitor along with the salmon sperm DNA; 4 – the same as 2, but
a 50-fold molar excess of the oligonucleotide binding site for F326
was added as a competitor along with the salmon sperm DNA
CO326
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Alpha-globin S/MAR
1               2            3            4
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A
Bisolated nuclear matrix. We checked this directly using
the in vitro MAR assay. Indeed, the F326 preferentially 
bound to the nuclear matrix as compared to the control
double-stranded oligonucleotide (5'-TATTTGATAGC-
AATATTTAGTATTT-3'; Fig. 1, C).
Oligonucleotide containing binding site for the
F326 protein enhances binding of heterologous MARs
to the nuclear matrix. The above results suggest that
the F326 protein may participate in organization of
DNA-binding sites on the nuclear skeleton. It is known
that some MARs of different origin compete with each
other in the MAR assay [6, 15]. In order to check
whether the oligonucleotide containing the binding site 
for the F326 protein can efficiently compete with
S/MARs of different origin, we have carried out a
MAR assay with the CO326 S/MAR and either the
S/MAR from the domain of chicken alpha-globin
genes or a S/MAR from the 5'-end of the human beta-
interferon gene domain [21]. In this experiment, F326
oligo inhibited binding of the CO326 S/MAR to the
nuclear matrix, but surprisingly, no competition
between the oligonucleotide and above-mentioned
MARs was observed, moreover the binding of both
S/MARs to the nuclear matrix was enhanced 2–4 fold
by a 25´–50´ molar excess of the F326 oligonucleotide
(Fig. 2). 
The above data are obviously in contradiction with
the idea that all MARs are structurally the same and,
hence, compete for binding to the nuclear matrix,
because if it was so, the F326 oligonucleotide would
compete with another MAR to a similar extent as the
CO326 S/MAR itself. One of the possible explanations
is the existence of a cluster of DNA-binding proteins in
the nuclear matrix. In this case, two MARs would
compete not for the same protein, but for a place in a
cluster. Oligonucleotide that binds to one protein in a
cluster will inhibit binding of a homologous MAR
while exerting no influence or even increasing the
binding of a heterologous MAR (Fig. 3). 
This explanation assumes that S/MARs are
structurally heterologous. Indeed, there are data that
both transcription and replication is accomplished at
the nuclear skeleton [22]. At the same time, the
interaction between DNA and the nuclear matrix also
exists in transcriptionally inactive nuclei or genomic
domains [23, 24]. These different types of interaction
may be mediated by different specific DNA-binding
matrix proteins. These proteins may include DNA
topoisomerase II, MeCP2 [25], a chicken matrix
attachment region protein [26, 27] or human
tissue-specific MAR binding proteins SATB1 [28] or
SATB2 [29]. 
Further studies will help us to understand in more
details the nature of MARs and their interaction with
DNA-binding matrix proteins.
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Fig. 3. A model of interaction between MARs and the cluster of DNA-binding matrix proteins: A – the S/MAR binding proteins are clustered
in the nuclear matrix; B – binding of one S/MAR (X) would prevent association of a heterologous S/MAR (Y) with the nuclear matrix because 
of the proximity of S/MAR binding proteins; C – binding of a small oligonucleotide containing the protein X binding site (oligo X) would
inhibit binding of the homologous S/MAR X, but would not interfere with binding of the heterologous S/MAR Y, thus increasing the
efficiency of its interaction with the nuclear matrix as compared to the case BFrance, the INCa to YSV, PICS 3207 to YSV and SVR, 
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ª. Ñ. Âà  ñåöü  êèé,  Î. Ñ. Þä³íêî  âà,  Ñ. Â. Ðàç³í
Á³ëêè, ÿê³ îïî  ñå  ðåäêîâóþòü ïðè  êð³ïëåííÿ ÄÍÊ äî ÿäåð  íîãî 
ìàò ðèê ñó,  ãå òå ðî ãåíí³  ³  óòâîðþþòü  êëàñ òåðè
Ðå çþ ìå
Ìåòà.  CO326,  ä³ëÿí êà  ïðè êð³ïëåí íÿ  äî  ÿäåð íî ãî  ìàò ðèê ñó,
ì³ñòèòü  ñàéò  çâ’ÿ çó âàí íÿ  ç  ÄÍÊ-çâ’ÿ çó âàëü íèì  á³ëêîì  F326.
Ìå òî äè. Äëÿ àíàë³çó ìàò  ðèêñó, âèä³ëå  íî  ãî ç êë³òèí  íî¿ ë³í³¿
HD3,  âè êî ðèñ òà íî  in  vitro  MAR-ìå òîä.    Ðå çóëü òà òè. Îë³ãî  -
íóê  ëå  î  òèä, ÿêèé ì³ñòèòü ñàéò çâ’ÿ  çó  âàí  íÿ á³ëêà F326, ³íã³áóº
çâ’ÿ  çó  âàí  íÿ  CO326 ç ÿäåð  íèì ìàò  ðèê  ñîì, ïðè öüî  ìó àñîö³àö³ÿ
ãå òå ðî ëîã³÷íèõ  ä³ëÿ íîê  ïðè êð³ïëåí íÿ  äî  ÿäåð íî ãî  ìàò ðèê ñó
çðîñ òàº.  Âû âî äû. Îäåð  æàí³ äàí³ ñâ³ä÷àòü ïðî òå, ùî ð³çí³
ÄÍÊ-çâ’ÿ çó âàëüí³  á³ëêè  óòâî ðþ þòü  êëàñ òå ðè  ó  ÿäåð íî ìó  ìàò -
ðèêñ³.
Êëþ  ÷îâ³ ñëî  âà: ÿäåðíèé ìàò  ðèêñ, âçàºìîä³ÿ ÄÍÊ–á³ëîê,
MAR, SAR.
 
Å. Ñ. Âà  ñåö  êèé, Å. Ñ. Þäèí  êî  âà, Ñ. Â. Ðà  çèí 
Áåë êè,  îïîñ ðå äó þ ùèå  ïðè êðåï ëå íèå  ÄÍÊ  ê  ÿäåð íî ìó 
ìàò ðèê ñó,  ãå òå ðî ãåí íû  è  îá ðà çó þò  êëàñ òå ðû
Ðå çþ ìå
Öåëü.  CO326,  ó÷àñ òîê  ïðè êðåï ëå íèÿ  ê  ÿäåð íî ìó  ìàò ðèê ñó,  ñî -
äåð æèò  ñàéò  ñâÿ çû âà íèÿ  ñ  ÄÍÊ-ñâÿ çû âà þ ùèì  áåë êîì  F326.
Ìå òî äû.  Äëÿ  àíà ëè çà  ìàò ðèê ñà,  âû äå ëåí íî ãî  èç  êëå òî÷ íîé  ëè -
íèè HD3, èñ  ïîëü  çî  âàí in vitro MAR-ìå  òîä. Ðå çóëü òà òû. Îëè  -
ãî íóê ëå î òèä,  ñî äåð æà ùèé  ñàéò  ñâÿ çû âà íèÿ  áåë êà  F326,
èí ãè áè ðó åò  ñâÿ çû âà íèå    CO326  ñ  ÿäåð íûì  ìàò ðèê ñîì,  ïðè
ýòîì  àñ ñî öè à öèÿ  ãå òå ðî ëî ãè÷ íûõ  ó÷àñ òêîâ  ïðè êðåï ëå íèÿ  ê
ÿäåð íî ìó  ìàò ðèê ñó  óâå ëè ÷è âà åò ñÿ.  Âû âî äû.  Ïî ëó ÷å íû ûå  äàí -
íûå  ñâè äå ò åëüñòâó þò  î  òîì,  ÷òî  ðàç ëè÷ íûå  ÄÍÊ-ñâÿ çû âà þ -
ùèå  áåë êè  îá ðà çó þò  êëàñ òå ðû  â  ÿäåð íîì  ìàò ðèê ñå.
Êëþ ÷å âûå  ñëî âà:  ÿäåð íûé  ìàò ðèêñ,  âçà è ìî äå éñòâèå  ÄÍÊ–
áå  ëîê,  MAR, SAR.
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